Compile Data Set for Download or QSAR
maximum 50k data
Found 10 Enz. Inhib. hit(s) with all data for entry = 1490
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM47184(US8980905, 110 | US9637499, Compound 110)
Affinity DataIC50:  2nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150197(US8980905, 104 | US9637499, Compound 104)
Affinity DataIC50:  4nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150199(US8980905, 106 | US9637499, Compound 106)
Affinity DataIC50:  5nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150194(US8980905, 101 | US9637499, Compound 101)
Affinity DataIC50:  6nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150196(US8980905, 103 | US9637499, Compound 103)
Affinity DataIC50:  6nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150198(US8980905, 105 | US9637499, Compound 105)
Affinity DataIC50:  7nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150201(US8980905, 109 | US9637499, Compound 109)
Affinity DataIC50:  13nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150195(US8980905, 102 | US9637499, Compound 102)
Affinity DataIC50:  13nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150200(US8980905, 108 | US9637499, Compound 108)
Affinity DataIC50:  16nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM47185(US8980905, 111 | US9637499, Compound 111)
Affinity DataIC50:  106nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent